Membrane-bound Fas ligand elicits protective anti-tumor immunity in the immune privileged eye

被引:0
|
作者
Gregory, MS
Repp, AC
Hohlbaum, AM
Marshak-Rothstein, A
Ksander, BR
机构
[1] Schepens Eye Res Inst, Boston, MA USA
[2] Boston Univ, Sch Med, Boston, MA 02118 USA
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
98
引用
收藏
页码:26 / 26
页数:1
相关论文
共 50 条
  • [41] Role of the innate and adaptive immune system in omental anti-tumor immunity
    Sedlacek, Abigail
    Gerber, Scott
    Lord, Edith
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [42] The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity
    Wu, Zhengguo
    Li, Shang
    Zhu, Xiao
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [43] Role of heat as a regulator of innate immune responses and anti-tumor immunity
    Ostberg, JR
    Pritchard, MT
    Ertel, BR
    Dayanc, BE
    Patel, R
    Repasky, EA
    FASEB JOURNAL, 2003, 17 (07): : C73 - C73
  • [44] Neuroimmune-mediated immune dysfunction of anti-tumor immunity.
    Kalinchenko, V
    Cohen, RL
    Graf, LH
    Chambers, DA
    JOURNAL OF DENTAL RESEARCH, 1998, 77 : 642 - 642
  • [45] Immune evasion of tumor cells using membrane-bound complement regulatory proteins
    Gorter, A
    Meri, S
    IMMUNOLOGY TODAY, 1999, 20 (12): : 576 - 582
  • [46] Functional Characterization of a Chimeric Soluble Fas Ligand Polymer with In Vivo Anti-Tumor Activity
    Daburon, Sophie
    Devaud, Christel
    Costet, Pierre
    Morello, Aurore
    Garrigue-Antar, Laure
    Maillasson, Mike
    Hargous, Nathalie
    Lapaillerie, Delphine
    Bonneu, Marc
    Dechanet-Merville, Julie
    Legembre, Patrick
    Capone, Myriam
    Moreau, Jean-Francois
    Taupin, Jean-Luc
    PLOS ONE, 2013, 8 (01):
  • [47] Protective immunity is induced in the mice inoculated with murine lung carcinoma cells expressing membrane-type Fas ligand but not soluble Fas ligand
    Tagawa, M
    Tada, Y
    Keiyo, O
    Takenaga, K
    Sakiyama, S
    CANCER GENE THERAPY, 2000, 7 (12) : S25 - S25
  • [48] Anti-tumor effects produced by the expression of fas ligand on tumor cells are mediated by the activation of dendritic cells
    Tagawa, M
    Tada, Y
    O-Wang, J
    Sakiyama, S
    CANCER GENE THERAPY, 2001, 8 : S28 - S28
  • [49] Induction of protective anti-tumor immunity by gene-modified dendritic cells
    McArthur, JG
    Mulligan, RC
    JOURNAL OF IMMUNOTHERAPY, 1998, 21 (01): : 41 - 47
  • [50] Protective anti-tumor immune responses in breast cancer depend on tumor mutation rate
    Miller, Lance D.
    Routh, Eric D.
    Chou, Jeff W.
    Thomas, Alexandra
    CANCER RESEARCH, 2017, 77